Age-dependent modulation of heparan sulfate structure and function (Q38337039)

2 September 2017

Age-dependent modulation of heparan sulfate structure and function (English)

1 reference

2 September 2017

4

Lindahl U

1 reference

2 September 2017

Feyzi E

1

1 reference

2 September 2017

Saldeen T

series ordinal

2

1 reference

2 September 2017

Larsson E

series ordinal

3

1 reference

2 September 2017

Salmivirta M

series ordinal

5

1 reference

2 September 2017

language of work or name

English

0 references

publication date

1 May 1998

1 reference

Journal of Biological Chemistry

2 September 2017

1 reference

2 September 2017

273

1 reference

2 September 2017

13395-13398

1 reference

2 September 2017

22

1 reference

Proteoglycans: structures and interactions

2 September 2017

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.22.13395

Domain structure of heparan sulfates from bovine organs

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.22.13395

Heparin structure and interactions with basic fibroblast growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.22.13395

Characterization of heparin and heparan sulfate domains binding to the long splice variant of platelet-derived growth factor A chain

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.22.13395

Structural requirement of heparan sulfate for interaction with herpes simplex virus type 1 virions and isolated glycoprotein C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.22.13395

Molecular organization of the interferon gamma-binding domain in heparan sulphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.22.13395

Mode of interaction between platelet factor 4 and heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.22.13395

Developmental regulation of neural response to FGF-1 and FGF-2 by heparan sulfate proteoglycan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.22.13395

Structure of heparan sulphate from human brain, with special regard to Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.22.13395

The pathogenesis of atherosclerosis: a perspective for the 1990s

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.22.13395

Heparan sulfate proteoglycans are primarily responsible for the maintenance of enzyme activity, binding, and degradation of lipoprotein lipase in Chinese hamster ovary cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.22.13395

Endothelial cell-derived basic fibroblast growth factor: synthesis and deposition into subendothelial extracellular matrix

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.22.13395

Receptor- and heparin-binding domains of basic fibroblast growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.22.13395

Compartmentalization of PDGF on extracellular binding sites dependent on exon-6-encoded sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.22.13395

PDGF-AA and PDGF-BB biosynthesis: proprotein processing in the Golgi complex and lysosomal degradation of PDGF-BB retained intracellularly

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.22.13395

Selective loss of cerebral keratan sulfate in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.22.13395

The disaccharide composition of heparins and heparan sulfates

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.22.13395

Alternative splicing determines the binding of platelet-derived growth factor (PDGF-AA) to glycosaminoglycans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.22.13395

Formation of anhydrosugars in the chemical depolymerization of heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.22.13395

21 January 2018

Identifiers

DOI

10.1074/JBC.273.22.13395

1 reference

2 September 2017

1 reference